Epilepsia Open

Papers
(The H4-Index of Epilepsia Open is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Brain‐responsive corticothalamic stimulation in the pulvinar nucleus for the treatment of regional neocortical epilepsy: A case series55
Managing depression and anxiety in people with epilepsy: A survey of epilepsy health professionals by the ILAE Psychology Task Force48
Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe45
Proposal to optimize evaluation and treatment of Febrile infection‐related epilepsy syndrome (FIRES): A Report from FIRES workshop42
Addressing neuropsychological diagnostics in adults with epilepsy: Introducing the International Classification of Cognitive Disorders in Epilepsy: The IC CODE Initiative38
FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force33
The gut microbiome in drug‐resistant epilepsy31
Serotonin receptors in epilepsy: Novel treatment targets?28
Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modificatio28
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program27
EEG datasets for seizure detection and prediction— A review23
Antiepileptogenesis and disease modification: Clinical and regulatory issues22
Glymphatic system dysfunction in temporal lobe epilepsy patients with hippocampal sclerosis22
An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European20
Why child neurologists talk about SUDEP: Results from two cross‐sectional surveys20
Acetazolamide: Old drug, new evidence?20
Impact of diagnostic delay on seizure outcome in newly diagnosed focal epilepsy19
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges18
1.686891078949